Hyperuricemia is associated with an increased prevalence of ventricular tachycardia and fibrillation in patients with ST-elevation myocardial infarction after primary percutaneous coronary intervention

Table 4 Association between hyperuricemia and the risk of VT/VF in STEMI patients undergoing PPCI

Logistics regression models	OR	95% CI	p value
Hyperuricemia
Unadjusted model	2.11	1.11–4.03	0.024
Adjusted model 1	2.45	1.34–4.54	0.004
Adjusted model 2	2.73	1.19–6.27	0.018
Other independent risk factors in model 2
Hypertension	2.31	1.08–4.97	0.032
LDL-C	1.76	1.11–2.80	0.017

VT, ventricular tachycardia; VF, ventricular fibrillation; STEMI, ST-segment elevation myocardial infarction; PPCI, primary percutaneous coronary intervention; LDL-C, low density lipoprotein cholesterol

ISSN: 1471-2261